This software stock is nearing the buy point of a newly formed flat base. Here's how Merck is expanding its long-term partnership with Veeva Systems.

Veeva Systems is Thursday's IBD Stock Of The Day as shares trade inside a flat base ahead of the looming divorce from ...

Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ...

Veeva Systems (VEEV) recently experienced a 31% increase in share price over the last quarter, a period marked by significant developments for the company. Key to this movement was Merck's commitment ...

Veeva Systems reported fiscal first-quarter results Wednesday that beat expectations, but weren't too exciting. The stock soared in response to management's outlook, which implies stronger growth ...

Veeva Systems has nearly tripled revenues and earnings over the past five years, but the stock's getting beaten down so badly that investors are starting to wonder if it's still a smart buy. ...

Veeva Systems' cloud-based platform, including Veeva CRM, Veeva Vault, and Veeva Network, offers a comprehensive suite of tools for managing product information, clinical trials, ...

Veeva Systems (NYSE: VEEV) offers cloud-based software solutions worldwide for the life sciences industry. Its products help pharmaceutical, biotech, and medical device companies manage clinical ...

I rate Veeva Systems (VEEV) as a buy due to the recent 0.5% interest rate cut from the FED, boosting demand from recovering SMB biotech firms. Read why here.

Veeva Systems is a cloud software provider with products designed specifically for the life sciences industry. Veeva Systems reported fiscal fourth-quarter earnings on Wednesday, March 1, 2023 ...